Roman C. Brands

997 total citations
58 papers, 729 citations indexed

About

Roman C. Brands is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Roman C. Brands has authored 58 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Surgery. Recurrent topics in Roman C. Brands's work include RNA Interference and Gene Delivery (12 papers), Head and Neck Cancer Studies (11 papers) and Immunotherapy and Immune Responses (10 papers). Roman C. Brands is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Head and Neck Cancer Studies (11 papers) and Immunotherapy and Immune Responses (10 papers). Roman C. Brands collaborates with scholars based in Germany, United States and Austria. Roman C. Brands's co-authors include Stefan Hartmann, Urs Müller‐Richter, Alexander Kübler, Christian Linz, Axel Seher, Christian Betz, Andreas Vollmer, Almoatazbellah Youssef, Gernot Hochleitner and Michael Vollmer and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and International Journal of Environmental Research and Public Health.

In The Last Decade

Roman C. Brands

55 papers receiving 722 citations

Peers

Roman C. Brands
Roman C. Brands
Citations per year, relative to Roman C. Brands Roman C. Brands (= 1×) peers Kei Tomihara

Countries citing papers authored by Roman C. Brands

Since Specialization
Citations

This map shows the geographic impact of Roman C. Brands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman C. Brands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman C. Brands more than expected).

Fields of papers citing papers by Roman C. Brands

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman C. Brands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman C. Brands. The network helps show where Roman C. Brands may publish in the future.

Co-authorship network of co-authors of Roman C. Brands

This figure shows the co-authorship network connecting the top 25 collaborators of Roman C. Brands. A scholar is included among the top collaborators of Roman C. Brands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman C. Brands. Roman C. Brands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfaehler, Elisabeth, Andreas Schindele, Alexander Dierks, et al.. (2025). Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma. Scientific Reports. 15(1). 17475–17475. 1 indexed citations
2.
Kübler, Alexander, Andreas Vollmer, Tobias Renner, et al.. (2024). Comparison of Patient-Specific Condylar Positioning Devices and Manual Methods in Orthognathic Surgery: A Prospective Randomized Trial. Journal of Clinical Medicine. 13(3). 737–737. 1 indexed citations
3.
Vollmer, Andreas, Stefan Hartmann, Michael Vollmer, et al.. (2024). Multimodal artificial intelligence-based pathogenomics improves survival prediction in oral squamous cell carcinoma. Scientific Reports. 14(1). 5687–5687. 13 indexed citations
4.
Brands, Roman C., Hartmut Böhm, Alexander Kübler, et al.. (2023). Kraniofaziale Mikrosomie. 16(2). 173–182.
5.
Vollmer, Andreas, Michael Vollmer, Gernot Lang, et al.. (2023). Automated Assessment of Radiographic Bone Loss in the Posterior Maxilla Utilizing a Multi-Object Detection Artificial Intelligence Algorithm. Applied Sciences. 13(3). 1858–1858. 5 indexed citations
6.
Schulz, Stefan M., et al.. (2022). Oral-Health-Related Quality of Life in Patients with Medication-Related Osteonecrosis of the Jaw: A Prospective Clinical Study. International Journal of Environmental Research and Public Health. 19(18). 11709–11709. 12 indexed citations
7.
Vollmer, Andreas, Thiên‐Trí Lâm, Roman C. Brands, et al.. (2022). Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam. Clinical Oral Investigations. 26(12). 7033–7044. 17 indexed citations
8.
Linz, Christian, Roman C. Brands, Olivia Kertels, et al.. (2021). Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity – initial experience and comparison to [18F]FDG PET/CT and MRI. European Journal of Nuclear Medicine and Molecular Imaging. 48(12). 3951–3960. 37 indexed citations
9.
Brands, Roman C., Stefan Hartmann, Axel Seher, et al.. (2020). Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro. Journal of Cranio-Maxillofacial Surgery. 48(7). 685–693. 4 indexed citations
10.
Seher, Axel, Christian Linz, Stefan Hartmann, et al.. (2019). Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro. Journal of Cranio-Maxillofacial Surgery. 47(10). 1589–1599. 14 indexed citations
11.
Youssef, Almoatazbellah, Axel Seher, Stefan Hartmann, et al.. (2019). A new multilayered membrane for tissue engineering of oral hard- and soft tissue by means of melt electrospinning writing and film casting – An in vitro study. Journal of Cranio-Maxillofacial Surgery. 47(4). 695–703. 22 indexed citations
12.
Moratin, Julius, Urs Müller‐Richter, Roman C. Brands, et al.. (2018). Squamous cell carcinoma of the maxilla: Analysis of clinicopathological predictors for disease recurrence and metastatic behavior. Journal of Cranio-Maxillofacial Surgery. 46(4). 611–616. 18 indexed citations
13.
Hartmann, Stefan, Roman C. Brands, Axel Seher, et al.. (2017). MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer. Clinical Oral Investigations. 22(3). 1477–1486. 15 indexed citations
14.
Brands, Roman C., et al.. (2017). Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro. Oncology Reports. 38(3). 1877–1885. 23 indexed citations
15.
Brands, Roman C., Stefan Hartmann, Axel Seher, et al.. (2016). Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines. Clinical Oral Investigations. 20(9). 2325–2332. 15 indexed citations
16.
Brands, Roman C., Urs Müller‐Richter, Axel Seher, et al.. (2016). Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin. Molecular Medicine Reports. 13(3). 2338–2344. 14 indexed citations
17.
Hartmann, Stefan, Karen Ernestus, Christian Linz, et al.. (2016). Mandibular intraosseous pseudocarcinomatous hyperplasia: a case report. Journal of Medical Case Reports. 10(1). 268–268. 2 indexed citations
18.
Hartmann, Stefan, Till Meyer, Roman C. Brands, et al.. (2015). MAGE-A expression clusters and antineoplastic treatment in head and neck cancer. International Journal of Molecular Medicine. 35(6). 1675–1682. 9 indexed citations
19.
Hartmann, Stefan, Axel Seher, Roman C. Brands, et al.. (2014). Influence of epidermal growth factor receptor expression on the cetuximab and panitumumab response rates of head and neck carcinoma cells. Journal of Cranio-Maxillofacial Surgery. 42(7). 1322–1328. 15 indexed citations
20.
Hartmann, Stefan, et al.. (2013). Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells. Clinical Oral Investigations. 18(1). 189–197. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026